HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$9.25
Year range
$4.23 - $12.62
Market cap
151.61M USD
Avg Volume
81.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.09M | -7.63% |
Net income | -10.56M | -46.09% |
Net profit margin | — | — |
Earnings per share | -0.66 | -3.13% |
EBITDA | -10.04M | 7.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.09M | 544.91% |
Total assets | 29.53M | 87.48% |
Total liabilities | 27.69M | 59.14% |
Total equity | 1.83M | — |
Shares outstanding | 16.32M | — |
Price to book | 84.09 | — |
Return on assets | -87.49% | — |
Return on capital | -160.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -10.56M | -46.09% |
Cash from operations | -8.95M | -0.25% |
Cash from investing | — | — |
Cash from financing | 11.93M | 3,675.95% |
Net change in cash | 3.06M | 135.15% |
Free cash flow | -4.88M | 12.61% |
About
Founded
2011
Headquarters
Website
Employees
32
